Archives by Tag 'Boniva'

FDA says Osteoporosis Drug Labels Must Warn Patients of Risk of Leg Fractures

The U.S. Food and Drug Administration (FDA) announced today that the agency is requiring the labels of bisphosphonate osteoporosis drugs Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia and Reclast (and their generic products) to include a warning about increased risk of fracture of the thigh bone. Doctors prescribe these bisphosphonates for the [...]

Common Osteoporosis Drugs Could Double Esophageal Cancer Risk

A new study released Thursday has found that people who take a class of osteoporosis drugs called bisphosphonates such as Actonel (Risedronate), Boniva (Ibandronate) and Fosamax (alendronate) for more than five years may have double the risk of developing cancer of the esophagus. The study entitled “Oral bisphosphonates and risk of cancer of oesophagus, stomach, [...]